People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biolinq Inc | — | Biotechnology | Series C | $247.4M | $619.1M | 2021 |
| Alume Biosciences Inc | — | Biotechnology | Series A | $33.4M | $18.9M | 2022 |
| Freedom Meditech Inc | — | Other | Series A | $13.2M | $73.8M | 2014 |
Dan Bradbury at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dan Bradbury on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martin J. Waters | 1 | 9 |
| Daniel Bradbury | 1 | 7 |
| Magda Marquet | 1 | 6 |
| Kim Kamdar | 1 | 6 |
| Nancy Hong | 1 | 4 |
| Zina Affas Besse | 1 | 4 |
| James Schmidt | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Jean-Pierre Millon | 1 | 3 |
| Andy Sassine | 1 | 2 |
| Kaveri Parker | 1 | 2 |
| Brett Berman | 1 | 2 |
| Deepak D Chopra | 1 | 2 |
| Lana Ghanem | 1 | 2 |
| Magda T. Marquet | 1 | 2 |
| RICHARD YANG | 1 | 2 |
| John Burd | 1 | 1 |
| Craig Misrach | 1 | 1 |
| James T. Schmidt | 1 | 1 |
| Catherine Stiefel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.